| How to Verify Peptide COAs |
Quality & Testing |
Lot traceability, HPLC-UV + LC-MS cross-check, metadata forensics, direct lab confirmation |
Freedom Diagnostics / Oath Research (more than 500 batches, more than half of the certificates) |
| HPLC Chromatogram Interpretation Guide |
Quality & Testing |
Reverse-phase C18 gradients, 214 nm peptide bond absorbance, peak symmetry, baseline integration |
USP <621> Chromatography · 99.64% (trailing-12-month average) |
| Mass Spectrometry Identity Guide |
Quality & Testing |
ESI-MS multiply charged ions ([M+nH]n+), MALDI-TOF monoisotopic mass, Na/K/TFA adducts |
USP <736> Mass Spectrometry · ±0.1 Da tolerance |
| Understanding Peptide Purity vs. Net Content |
Quality & Testing |
Chromatographic peak area % vs. net peptide content (NPC), counterion stoichiometry |
CHN Elemental / Amino Acid Analysis · Gross vs. Net mg |
| Bacterial Endotoxin Testing Guide |
Quality & Testing |
Lipopolysaccharide (LPS) contamination, chromogenic & turbidimetric LAL assays, rFC methods |
USP <85> Bacterial Endotoxins Test (<5 EU/mg threshold) |
| Independent Third-Party Testing Guide |
Quality & Testing |
Blind sample submission, chain-of-custody sealing, analytical panel selection, cost modeling |
Independent contract labs (Freedom Diagnostics, MZ Biolabs) |
| Analytical Laboratory Accreditation |
Quality & Testing |
ISO/IEC 17025 testing scopes, ANAB/A2LA/ILAC directories, method validation parameters |
ISO/IEC 17025:2017 & USP <1058> Analytical Instrument Qualification |
| Peptide Manufacturing Standards |
Quality & Testing |
Fmoc/tBu solid-phase synthesis, preparative RP-HPLC purification, counterion exchange, lyophilization |
ICH Q7 Good Manufacturing Practice for APIs |
| Quality Standards Comparison |
Quality & Testing |
Side-by-side audit of Research-Grade, Institutional cGMP API, and 503A/503B Compounding tiers |
ICH Q7 · 21 CFR 210/211 · USP <797> · ISO/IEC 17025 |
| Lyophilized Solvent Dissolution & Stock Preparation |
Lab Operations |
Isoelectric point (pI) buffer selection, gravimetric stock math (C = m/V), molarity (M), aseptic hydration |
Analytical stock preparation SOP · Zero human dosing |
| Thermal Stability & Cold-Chain Storage |
Lab Operations |
Arrhenius degradation kinetics, deamidation/oxidation rates, −80°C vs. −20°C vs. 4°C |
USP <1079> Good Storage Practices · Single-use aliquoting |
| Lyophilized Cake & Aliquot Handling |
Lab Operations |
Hygroscopic moisture prevention, desiccant equilibration, borosilicate vs. polypropylene adsorption |
Karl Fischer residual moisture (<3% w/w) |
| Laboratory Peptide & Solvent Disposal |
Lab Operations |
Oxidative sodium hypochlorite cleavage, sharps/glassware containment, organic mobile phase waste |
OSHA 29 CFR 1910.1450 Laboratory Chemical Hygiene |
| Tissue Repair Peptide Assay Handling |
Lab Operations |
In-vitro endothelial tube formation & fibroblast scratch assays for BPC-157, TB-500, and GHK-Cu |
Preclinical angiogenic & cytoprotective assay buffers |
| Somatotropic & Secretagogue Assay Handling |
Lab Operations |
Pituitary somatotroph receptor binding and cAMP/IP3 reporter assays for GHRH/GHRP analogs |
GHS-R1a & GHRH-R in-vitro radioligand / FRET protocols |
| Geroprotective & Mitochondrial Peptide Handling |
Lab Operations |
Telomerase TRAP assays, mitochondrial stress models, and tetrapeptide oxidation control |
Epithalon, Humanin & MOTS-c cell culture stock buffers |
| Neuropeptide & BDNF Pathway Assay Handling |
Lab Operations |
Primary neuronal culture preparation, peptidase inhibition, and Methionine oxidation prevention |
Semax, Selank & Dihexa analytical stability profiles |
| Neuroprotective Peptide Stability & Assay Prep |
Lab Operations |
Oxidative glutamate toxicity models, oligomeric aggregation prevention, low-binding plastics |
In-vitro neuroprotection & synaptic plasticity models |
| Extracellular Matrix & Senescence Model Handling |
Lab Operations |
Dermal fibroblast collagen I/III synthesis, MMP zymography, and Cu(II) coordination stability |
GHK-Cu, Thymosin Beta-4 & matrix remodeling assays |
| Myogenic & Cellular Recovery Assay Handling |
Lab Operations |
C2C12 myoblast differentiation, actin polymerization kinetics, and splice-variant stability |
IGF-1 LR3, PEG-MGF & Thymosin Beta-4 fragment handling |